Unveiling functional motions based on point mutations in biased signaling systems: A normal mode study on nerve

Pedro Túlio Resende-Lara1,2, David Perahia2, Ana Lígia Scott1

  • 1Laboratório de Biologia Computacional e Bioinformática, Universidade Federal do ABC, Santo André, São Paulo, Brazil.

Plos One
|June 5, 2020
PubMed

Insights

Biased signaling, where ligands activate specific receptor pathways, is key for drug development. This study reveals how a specific mutation in NGF disrupts TrkA receptor motions, impairing nociceptive signaling and offering insights for new drug design.

Area of Science:

  • Molecular Biology
  • Biophysics
  • Neuroscience

Background:

  • Receptor signaling involves complex intracellular pathways.
  • Biased signaling, triggered by specific ligands, preferentially activates certain pathways.
  • Understanding these pathways is crucial for targeted drug development.

Purpose of the Study:

  • To identify specific functional motions in receptor signaling.
  • To investigate the impact of mutations on these motions using the NGF/TrkA-Ig2 complex as a model.
  • To explore the link between structural changes, functional alterations, and disease.

Main Methods:

  • Utilized normal mode analysis.
  • Integrated experimental observations of functional alterations due to point mutations.
  • Focused on the NGF/TrkA-Ig2 complex and the R221W mutation in the NGF gene.

Main Results:

  • Demonstrated the detection of specific functional motions linked to distinct signaling pathways.
  • Showed that the R221W mutation in NGF impairs nociceptive signaling by suppressing collective motions necessary for TrkA activation.
  • Identified that subtle changes in the NGF interaction network can inhibit TrkA receptor motions associated with nociception.

Conclusions:

  • The presented methodology effectively reveals structural changes and motions linked to disease.
  • This approach provides a valuable tool for drug design studies targeting specific signaling pathways.
  • Understanding mutation-induced alterations in receptor dynamics is essential for developing effective and specific therapeutics.